Company: CRAC
Filing Date: 2025-07-16
Form Type: S-1/A
Source: 0001213900-25-064764
Chunk: 205

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-07-16
Form: S-1/A
Chunk 205
---
 end of that year’s second fiscal quarter, or (2) our annual revenues exceeded $100 million during such completed fiscal year and the market value of our ordinary shares held by non -affiliatesexceeds $700 million as of the end of that year’s second fiscal quarter. Legal Proceedings There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such, and we and the members of our management team have not been subject to any such proceeding in the 12 months preceding the date of this prospectus. 131

MANAGEMENT Directors, Director Nominees, and Officers

| Name                |     | Age |     | Position                          |
| Prashant Patel      |     |  51 |     | Chief Executive Officer, Chairman |
| Eric Sherb          |     |  38 |     | Chief Financial Officer, Director |
| Michael L. Peterson |     |  63 |     | Director Nominee                  |
| Donald G. Fell      |     |  79 |     | Director Nominee                  |
| Avinash Wadhwani    |     |  57 |     | Director Nominee                  |
| Mayur Doshi         |     |  63 |     | Director Nominee                  |

Prashant Patel(age: 51) serves as Chairman and Chief Executive Officer. Mr. Patel currently serves on the board of Wellgistics Health, Inc. (NASDAQ: WGRX) and has previously served on the boards of TRxADE Health, Inc. (NASDAQ: MEDS) and Sceinture Holdings, Inc. (NASDAQ: SCNX). Additionally, Mr. Patel has been a board advisor to several special purpose acquisition companies over the years including Oceantech Acquisitions I Corp, (NASDAQ: OTAC), Aspire Biopharma Inc. (NASDAQ: PWUP), and Aesther Healthcare Acquisition Corp. (n/k/a Ocean Biomedical, Inc. (NASDAQ: OCEA)). Mr. Patel is a seasoned entrepreneur and a registered pharmacist with experience in multiple aspects of the pharmaceutical, biotech and healthcare industries. Mr. Patel previously started several starts -upsincluding Retail/Community Pharmacy before expanding into pharmaceuticals distribution and sales, focusing on pharmaceutical disposal and reverse distribution. Mr. Patel has also been a consultant to several return logistics pharmaceutical companies over the years. Mr. Patel possesses an excellent vision to bring transparency, efficiency and cost benefits to US pharmaceutical channel partners